A predictive tool for selecting HBeAg-positive chronic hepatitis B patients who have a high probability of HBV DNA suppression and HBeAg seroconversion with peginterferon alfa-2a

被引：0
|
作者：
Chan, Henry Lik-Yuen [1 ,2 ]
Papatheodoridis, George V. [3 ]
Messinger, Diethelm [4 ]
Bakalos, George [5 ]
Lampertico, Pietro [6 ]
机构：
[1] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China
[3] Univ Athens, Sch Med, Dept Gastroenterol, Laiko Gen Hosp, GR-11527 Athens, Greece
[4] IST GmbH, Mannheim, Germany
[5] F Hoffmann La Roche Ltd, Basel, Switzerland
[6] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Gastroenterol Unit 1, AM&A Migliavacca Ctr Liver Dis, Milan, Italy
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1886
引用
收藏
页码：1108A / 1108A
页数：1
相关论文
共 50 条
  • [31] Significance of T-Cell Subsets for Clinical Response to Peginterferon Alfa-2a Therapy in HBeAg-Positive Chronic Hepatitis B Patients
    Zhu, Li
    Li, Jin
    Xu, Junchi
    Chen, Fan
    Wu, Xunxun
    Zhu, Chuanwu
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 4441 - 4451
  • [32] COMPARISON OF PEGINTERFERON ALFA-2A VERSUS ENTECAVIR IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B WITH MILDLY ELEVATED ALANINE AMINOTRANSFERASE LEVELS
    Chen, X. -F.
    Chen, X. -P.
    Huang, J.
    Chen, W. -L.
    Chen, R.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S328 - S329
  • [33] Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2a
    Rinker, Franziska
    Bremer, Corinna M.
    Schroeder, Kathrin
    Wiegand, Steffen B.
    Bremer, Birgit
    Manns, Michael P.
    Kraft, Anke R.
    Wedemeyer, Heiner
    Yang, Lei
    Pavlovic, Vedran
    Wat, Cynthia
    Gerlich, Wolfram H.
    Glebe, Dieter
    Cornberg, Markus
    LIVER INTERNATIONAL, 2020, 40 (02) : 324 - 332
  • [34] Peginterferon Alfa-2a in Japanese HBeAg-Positive Patients is Not Inferior to Conventional Interferon Therapy
    Hayashi, Norio
    Kiyosawa, Kendo
    Tsubouchi, Hirohito
    Okanoue, Takeshi
    Kumada, Hiromitsu
    GASTROENTEROLOGY, 2011, 140 (05) : S930 - S930
  • [35] The combination of entecavir and peginterferon alfa-2a in HBeAg-positive immune tolerant (IT) adults with chronic hepatitis B virus (HBV) infection: Results of the HBRN IT Trial
    Feld, Jordan J.
    Terrault, Norah
    Belle, Steven H.
    Chung, Raymond T.
    Tsai, Naoky C.
    Khalili, Mandana
    Perrillo, Robert P.
    Cooper, Stewart
    Ghany, Marc G.
    Janssen, Harry L.
    Lok, Anna S.
    HEPATOLOGY, 2017, 66 : 485A - 486A
  • [36] COST-EFFECTIVENESS ANALYSIS OF PEGINTERFERON ALFA-2A (40KD) IN HBEAG-POSITIVE CHRONIC HEPATITIS B IN POLAND
    Jakubczyk, M.
    Paweska, J.
    Niewada, M.
    Berak, H.
    Szkultecka-Debek, M.
    Russel-Szymczyk, M.
    VALUE IN HEALTH, 2011, 14 (07) : A275 - A275
  • [37] Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trial
    Cheng, Jun
    Wang, Yuming
    Hou, Jinlin
    Luo, Duande
    Xie, Qing
    Ning, Qin
    Ren, Hong
    Ding, Huiguo
    Sheng, Jifang
    Wei, Lai
    Chen, Shijun
    Fan, Xiaoling
    Huang, Wenxiang
    Pan, Chen
    Gao, Zhiliang
    Zhang, Jiming
    Zhou, Boping
    Chen, Guofeng
    Wan, Mobin
    Tang, Hong
    Wang, Guiqiang
    Yang, Yuxiu
    Mohamed, Rosmawati
    Guan, Richard
    Lee, Tzong-Hsi
    Chang, Wen-Hsiung
    Huang Zhenfei
    Ye, Zhang
    Xu, Daozhen
    JOURNAL OF CLINICAL VIROLOGY, 2014, 61 (04) : 509 - 516
  • [38] The predictive value of early indicators for HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients with Telbivudine treatment for 104 weeks
    Wang, Juan
    Du, Ling-yao
    Zhu, Xia
    Chen, En-qiang
    Tang, Hong
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 33 : S20 - S25
  • [39] Efficacy Comparison of Tenofovir and Entecavir in HBeAg-Positive Chronic Hepatitis B Patients with High HBV DNA
    Shi, Hong
    Huang, Mingxing
    Lin, Guoli
    Li, Xiangyong
    Wu, Yuankai
    Jie, Yusheng
    Chong, Yutian
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [40] PEGINTERFERON LAMBDA FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB): A PHASE 2B COMPARISON WITH PEGINTERFERON ALFA IN PATIENTS WITH HBeAg-POSITIVE DISEASE
    Chan, H. L.
    Ahn, S. H.
    Chang, T. -T.
    Peng, C. -Y.
    Wong, D.
    Coffin, C. S.
    Lim, S. G.
    Chen, P. -J.
    Janssen, H. L.
    Marcellin, P.
    Serfaty, L.
    Zeuzem, S.
    Cohen, D.
    Critelli, L.
    Xu, D.
    Cooney, E.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S48 - S48
12345